• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Mephenytoin hydroxylation polymorphism: characterization of the enzymatic deficiency in liver microsomes of poor metabolizers phenotyped in vivo.

作者信息

Meier U T, Dayer P, Malè P J, Kronbach T, Meyer U A

出版信息

Clin Pharmacol Ther. 1985 Nov;38(5):488-94. doi: 10.1038/clpt.1985.213.

DOI:10.1038/clpt.1985.213
PMID:4053486
Abstract

The rate of 4-hydroxylation and of N-demethylation of S- and R-mephenytoin was determined in liver microsomes of 13 extensive (EM) and two poor (PM) metabolizers of mephenytoin. Detailed kinetic studies were performed in microsomes of eight EMs and the two PMs. Microsomal mephenytoin metabolism in PMs was characterized by an increased Km (150.6 and 180.6 vs. a mean [+/- SD] 37.8 +/- 9.6 mumol/L S-mephenytoin in 8 EMs), a decreased maximum rate of metabolism for S-mephenytoin hydroxylation (0.76 and 0.69 vs 4.85 +/- 1.65 nmol 4-hydroxymephenytoin per milligram protein per hour), and loss of stereoselectivity for the hydroxylation of the R- and S-enantiomers of mephenytoin (R/S ratio: 1.10 and 0.76 vs. 0.11 +/- 0.04 in 13 EMs). The formation of 4-OH-mephenytoin from R-mephenytoin and the demethylation reaction remained unaffected. These results support our hypothesis that the mephenytoin polymorphism is caused by a partial or complete absence or inactivity of a cytochrome P-450 isozyme with high affinity for S-mephenytoin.

摘要

相似文献

1
Mephenytoin hydroxylation polymorphism: characterization of the enzymatic deficiency in liver microsomes of poor metabolizers phenotyped in vivo.
Clin Pharmacol Ther. 1985 Nov;38(5):488-94. doi: 10.1038/clpt.1985.213.
2
The molecular mechanisms of two common polymorphisms of drug oxidation--evidence for functional changes in cytochrome P-450 isozymes catalysing bufuralol and mephenytoin oxidation.药物氧化两种常见多态性的分子机制——催化布呋洛尔和美芬妥因氧化的细胞色素P-450同工酶功能改变的证据
Xenobiotica. 1986 May;16(5):449-64. doi: 10.3109/00498258609050251.
3
Polymorphism in hydroxylation of mephenytoin and hexobarbital stereoisomers in relation to hepatic P-450 human-2.
Clin Pharmacol Ther. 1990 Mar;47(3):313-22. doi: 10.1038/clpt.1990.34.
4
Mephenytoin-type polymorphism of drug oxidation: purification and characterization of a human liver cytochrome P-450 isozyme catalyzing microsomal mephenytoin hydroxylation.
Biochim Biophys Acta. 1986 Dec 10;884(3):435-47. doi: 10.1016/0304-4165(86)90194-7.
5
Enzymatic basis of the debrisoquine/sparteine-type genetic polymorphism of drug oxidation. Characterization of bufuralol 1'-hydroxylation in liver microsomes of in vivo phenotyped carriers of the genetic deficiency.药物氧化的去甲丙咪嗪/鹰爪豆碱型遗传多态性的酶学基础。对遗传缺陷的体内表型携带者肝脏微粒体中布呋洛尔1'-羟化作用的表征。
Biochem Pharmacol. 1987 Dec 1;36(23):4145-52. doi: 10.1016/0006-2952(87)90573-9.
6
Lack of low Km diazepam N-demethylase in livers of poor metabolizers for S-mephenytoin 4'-hydroxylation.S-美芬妥因4'-羟化代谢能力差者的肝脏中缺乏低Km地西泮N-脱甲基酶。
Pharmacogenetics. 1994 Dec;4(6):323-31. doi: 10.1097/00008571-199412000-00005.
7
Reappraisal of human CYP isoforms involved in imipramine N-demethylation and 2-hydroxylation: a study using microsomes obtained from putative extensive and poor metabolizers of S-mephenytoin and eleven recombinant human CYPs.对参与丙咪嗪N-去甲基化和2-羟基化的人细胞色素P450同工酶的重新评估:一项使用从推定的S-美芬妥因广泛代谢者和代谢不良者以及11种重组人细胞色素P450中获得的微粒体进行的研究。
J Pharmacol Exp Ther. 1997 Jun;281(3):1199-210.
8
Characterization and inhibition of mephenytoin 4-hydroxylase activity in human liver microsomes.人肝微粒体中美芬妥英4-羟化酶活性的表征与抑制
J Pharmacol Exp Ther. 1987 Jan;240(1):216-22.
9
Mephenytoin hydroxylation deficiency in Caucasians: frequency of a new oxidative drug metabolism polymorphism.高加索人中美芬妥英羟化缺乏症:一种新的氧化药物代谢多态性的频率
Clin Pharmacol Ther. 1984 Dec;36(6):773-80. doi: 10.1038/clpt.1984.256.
10
Polymorphic metabolism of mephenytoin in man: pharmacokinetic interaction with a co-regulated substrate, mephobarbital.美芬妥因在人体内的多态性代谢:与共同调节底物美索比妥的药代动力学相互作用。
Clin Pharmacol Ther. 1986 Jun;39(6):646-53. doi: 10.1038/clpt.1986.113.

引用本文的文献

1
Identification of human liver cytochrome P450 isoforms mediating omeprazole metabolism.介导奥美拉唑代谢的人肝细胞色素P450同工酶的鉴定。
Br J Clin Pharmacol. 1993 Dec;36(6):521-30. doi: 10.1111/j.1365-2125.1993.tb00410.x.
2
Comparison of (S)-mephenytoin and proguanil oxidation in vitro: contribution of several CYP isoforms.体外(S)-美芬妥因与氯胍氧化的比较:几种细胞色素P450同工酶的作用
Br J Clin Pharmacol. 1999 Aug;48(2):158-67. doi: 10.1046/j.1365-2125.1999.00005.x.
3
In vitro proguanil activation to cycloguanil by human liver microsomes is mediated by CYP3A isoforms as well as by S-mephenytoin hydroxylase.
人肝微粒体将体外氯胍激活为环氯胍是由CYP3A亚型以及S-美芬妥因羟化酶介导的。
Br J Clin Pharmacol. 1994 May;37(5):413-20. doi: 10.1111/j.1365-2125.1994.tb05707.x.
4
Assessment of liver metabolic function. Clinical implications.肝脏代谢功能评估。临床意义。
Clin Pharmacokinet. 1994 Sep;27(3):216-48. doi: 10.2165/00003088-199427030-00005.
5
Characterisation of theophylline metabolism in human liver microsomes.人肝微粒体中茶碱代谢的表征
Br J Clin Pharmacol. 1987 Sep;24(3):293-300. doi: 10.1111/j.1365-2125.1987.tb03172.x.
6
Relationship between mephenytoin oxidation polymorphism and phenytoin, methylphenytoin and phenobarbitone hydroxylation assessed in a phenotyped panel of healthy subjects.在一组健康受试者的表型样本中评估甲妥英氧化多态性与苯妥英、甲笨妥英及苯巴比妥羟基化之间的关系。
Br J Clin Pharmacol. 1990 Jun;29(6):665-71. doi: 10.1111/j.1365-2125.1990.tb03687.x.
7
Lack of defect in oxidative hydroxylation of debrisoquine in a patient with halothane hepatitis.氟烷性肝炎患者中去甲丙咪嗪氧化羟基化无缺陷。
Eur J Clin Pharmacol. 1990;38(6):633-4. doi: 10.1007/BF00278596.
8
Mephenytoin stereoselective elimination in the rat: III. Stereoselective time course of induction during chronic hepatic portal vein administration.美芬妥英在大鼠体内的立体选择性消除:III. 慢性肝门静脉给药期间诱导的立体选择性时间进程。
Eur J Drug Metab Pharmacokinet. 1990 Jul-Sep;15(3):245-51. doi: 10.1007/BF03190211.
9
In vitro metabolism of the biguanide antimalarials in human liver microsomes: evidence for a role of the mephenytoin hydroxylase (P450 MP) enzyme.双胍类抗疟药在人肝微粒体中的体外代谢:美芬妥英羟化酶(P450 MP)酶作用的证据。
Br J Clin Pharmacol. 1990 Aug;30(2):287-91. doi: 10.1111/j.1365-2125.1990.tb03777.x.
10
Limitation to the use of the urinary S-/R-mephenytoin ratio in pharmacogenetic studies.尿中S-/R-美芬妥英比值在药物遗传学研究中的应用局限性。
Br J Clin Pharmacol. 1991 Mar;31(3):350-2. doi: 10.1111/j.1365-2125.1991.tb05542.x.